Trump Victory a ‘Modest Positive’ for Biopharma Industry: Analysts

Analyst reactions to Donald Trump’s election victory were mixed Wednesday, with potential positives including an FTC that is likely to be more friendly to M&A, and negatives including concerns about what role Robert F. Kennedy, Jr. might play in healthcare.

Scroll to Top